Design, synthesis and biological evaluation of bisthiazole-based trifluoromethyl ketone derivatives as potent HDAC inhibitors with improved cellular efficacy

A series of bisthiazole-based compounds with a trifluoromethyl ketone as the ZBG display potent inhibitory activity towards human HDACs and improved antiproliferative activity in several cancer cell lines.105